Alnylam Pharmaceuticals Inc ALNY Price Prediction & Forecast



Forecast

ALNY Stock Price Prediction

Alnylam Pharmaceuticals Inc

$296.11

-4.32%

$-13.37

At close: May 01, 16:00:00 GMT-4

$297.09

0.33%

$0.97

Pre-market: May 04, 06:59:45 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$309.49

Open

$307.46

Day's Range

$295.79 - $311.88

52 week range

$214.76 - $495.55

Volume

1.1M

Avg.Volume

1.4M

Dividend yield

EPS (TTM)

2.25

Market Cap

$39.4B

What is ALNY?

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The company is headquartered in Cambridge, Massachusetts and currently employs 2,500 full-time employees. The company went IPO on 2004-05-28. The firm is engaged in discovering, developing, manufacturing and commercializing novel therapeutics based on ribonucleic acid interference (RNAi). Its marketed products include AMVUTTRA (vutrisiran) for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR) with polyneuropathy in adults; ONPATTRO (patisiran) for the treatment of the polyneuropathy of hATTR amyloidosis in adults; GIVLAARI (givosiran) for the treatment of adults with acute hepatic porphyria; OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1, and Leqvio (inclisiran), which is being developed and commercialized by its partner, Novartis AG, for the treatment of adults with hypercholesterolemia or mixed dyslipidemia. The Company’s clinical development programs include Cemdisiran, Fitusiran, Zilebesiran, Elebsiran, Mivelsiran and ALN-HTT02. The company is developing Cemdisiran to treat complement-mediated diseases.

Features

Markets

News

According to analyst forecasts, we anticipate notable price fluctuations for ALNY in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $454.63. The lowest target is $238.36 and the highest is $594.3. Empower your investment choices with our cutting-edge, data-driven analysis!

ALNY Stock Price Prediction Summary

Top Analyst Ratings for ALNY

Based on 39 analysts giving stock ratings to ALNY, updated on Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for ALNY. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: ALNY is a Buy candidate.

ALNY stock price ended at $296.11 on Friday, after dropping 4.32%

On the latest trading day May 01, 2026, the stock price of ALNY fell by 4.32%, dropping from $308.76 to $296.11. During the session, the stock saw a volatility of 5.44%, with prices oscillating between a daily low of $295.79 and a high of $311.88. On the latest trading day, the trading volume for ALNY decreased by 1.0M shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 1.1M shares were traded, with a market value of approximately $39.2B.

ALNY Technical Signals

Technical Signals Summary

Buy Signals 0

Neutral Signals 2

Sell Signals 5

Strong Sell

Sell

Neutral

Buy

Strong Buy

ALNY currently exhibits 0 buy signals and 5 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -4.32% during this period. Overall, the technical indicators point to a Strong Sell outlook for the mid-term.

Bullish/Bearish Signals for ALNY

Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for ALNY. These insights help you make informed investment decisions.

Follow-Up Questions

How do technical analysis indicators apply to ALNY?



According to technical analysis, Alnylam Pharmaceuticals Inc has an aggregate signal of Strong Sell. Alnylam Pharmaceuticals Inc has 0 Buy signals, 2 Neutral Signals and 5 sell signals.

What are the Fibonacci retracement levels for ALNY?



The Fibonacci retracement level for Alnylam Pharmaceuticals Inc is between 23.6% and 38.2%

What is the RSI for Alnylam Pharmaceuticals Inc?



The RSI for Alnylam Pharmaceuticals Inc is currently 34.08, indicating a neutral condition

What is Alnylam Pharmaceuticals Inc price for the next 12 months?



Alnylam Pharmaceuticals Inc ALNY price for the next 12 months is estimated at $454.63.

How high is Alnylam Pharmaceuticals Inc expected to go?



According to wall street analysts, Alnylam Pharmaceuticals Inc is expected to reach a high forecast of $594.3.

Alnylam Pharmaceuticals Inc (ALNY) Stock Price Prediction

ALNY Stock Price Chart